维京治疗

最新新闻

• A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $87 to $125
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $101
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $71 to $114
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• J.P. Morgan Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Cuts Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 评级变动
  Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2026/8/1
• 评级变动
  Raymond James Maintains Viking Therapeutics(VKTX.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 评级变动
  B. Riley Securities Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) and Aytu BioScience (AYTU)
  TipRanks · 2026/9/23
• 评级变动
  Morgan Stanley Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• Cantor Fitzgerald Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Stifel Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $95
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Viking Therapeutics (VKTX)
  TipRanks · 2026/6/25
• 评级变动
  Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  CCORF Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $107
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  Analysts Are Bullish on Top Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX)
  TipRanks · 2026/9/23
• A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $70 to $114
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• 评级变动
  Piper Sandler Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $71
  \u5e02\u573a\u8d44\u8baf · 2026/7/7
• B. Riley Securities Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/9/9

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。